 Reuters UK | Advisers back Merck drug for some kidney patients Reuters By Alina Selyukh SILVER SPRING, Maryland (Reuters) - Health advisers on Wednesday unanimously recommended use of Merck & Co's cholesterol-lowering drug Vytorin for preventing stroke and other heart problems in patients with chronic kidney disease, ... FDA Advisory Committee Unanimously Recommends Approval of Merck's VYTORIN(R ... FDA Advisory Committee Recommends Approval for Vytorin in Pre-Dialysis CKD ... FDA Panel Says Vytorin Okay for Some Kidney Disease Patients |
